SHINE, Zeno Power to Partner
SHINE Technologies has partnered with Zeno Power, a developer of commercial Radioisotope Power Systems (RPSs), the company recently announced. According to a release, SHINE plans to provide Zeno with Strontium-90…
Tag Archives: SHINE Medical Technologies
SHINE, Blue Earth Therapeutics Partner
SHINE Technologies announced recently that it has partnered with Blue Earth Therapeutics, a company focused on developing innovative radiopharmaceuticals. According to a release, SHINE has provided to Blue Earth Therapeutics…
SHINE, Orano Sign MOU for Pilot Plant
SHINE Technologies has signed a Memorandum of Understanding (MOU) with Orano to cooperate in the development of the U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from…
SHINE, Nucleus RadioPharma Partner
SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…
SHINE Raises $70 Million
SHINE Technologies has raised $70 million in additional funding to accelerate the commercialization of near-term applications of fusion technology, the company announced today. The round was led by existing investors…
SHINE Achieves Visible Proof of Fusion
SHINE Technologies has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history, the company announced today. “Fusion has long captured…
SHINE Opens New Facility
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
SHINE Launches Radiation Effects Testing
SHINE Technologies is now offering state-of-the-art radiation effects testing, the company announced today. According to a release, the service, called FLARE (Fusion Linear Accelerator for Radiation Effects), will use high-energy…
SHINE, Radiopharm Theranostics Establish Agreement
SHINE Technologies and Radiopharm Theranostics signed a clinical supply agreement, in which SHINE will supply Radiopharm with isotope non-carrier-added lutetium-177 (Lu-177), the company announced recently. “One way or another, nearly…
Phoenix Names New CEO
SHINE Technologies named Tom D’Orazio as the CEO of Phoenix, the company announced recently. According to a release, D’Orazio has more than two decades of experience in sales leadership roles…
